MedTrace Logo

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

NCT01706432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2024-07-31

No results posted yet for this study

Summary

This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

Conditions

  • Central Nervous System Metastases
  • Invasive Ductal Breast Carcinoma
  • Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
  • Invasive Lobular Breast Carcinoma
  • Invasive Lobular Breast Carcinoma With Predominant in Situ Component
  • Liver Metastases
  • Lobular Breast Carcinoma in Situ
  • Lung Metastases
  • Male Breast Cancer
  • Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
  • Mucinous Ductal Breast Carcinoma
  • Papillary Ductal Breast Carcinoma
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • Tubular Ductal Breast Carcinoma
  • Tumors Metastatic to Brain

Interventions

RADIATION

hyperfractionated radiation therapy

Undergo hypofractionated radiation therapy

OTHER

laboratory biomarker analysis

Correlative studies

RADIATION

stereotactic radiosurgery

Undergo stereotactic radiosurgery

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Steven Chmura · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-15
Primary Completion
2024-01-22
Completion
2024-01-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01706432 on ClinicalTrials.gov